Prof. Dr. Torello Lotti
University of Studies Guglielmo Marconi, Roma, Italia

Future of Dermatology and Applied Cosmetology
Autor: Torello Lotti, Professor & Chairman of Dermatology and Regenerative Medicine, University of Rome “Guglielmo Marconi”, Rome, Italy   

Torello Lotti

University of Rome “Guglielmo Marconi”, Rome, Italy
President World Health Academy of Dermatology

Skin ageing is an irreversible process during which ultrastructural and physiologic alterations happen. Dermatology has focused a lot of attention on the reversal of signs of ageing and photodamage, with the purposes of achieving cosmetic benefits and preventing photocancerogenesis. Recent advances in skin biology have clarified the mechanisms by which photoageing occurs and have given rise to new treatments to prevent and reverse this process. The understanding of the role of key receptors involved in the complex pathomechanism of skin ageing probably will lead to the development of the new therapeutic agents in the near future.

Our contribution in Understanding an treating Covid-19 Skin Disorders

Torello Lotti

University of Rome “Guglielmo Marconi”, Rome, Italy
President World Health Academy of Dermatology

Keywords: COVID-19, SARS-CoV-2, acro-ischemia, androgenetic alopecia, chilblain-like eruptions, maculopapular rash, purpuric rash, urticaria

Coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the epithelium of the airways. With the increasing involvement of dermatologist in management of this crisis, cutaneous symptoms gained more and more attention. In this review, we will describe cutaneous symptoms of patients of all ages in association with COVID-19. We will focus on such disorders that are caused by direct action of SARS-CoV-2 on tissues, complement, and coagulation system and on nonspecific eruption of the systemic viral infection. Drug-induced reactions are only mentioned in the differential diagnoses. Although more systematic investigations are warranted, it becomes clear that some symptoms are clinical signs of a milder COVID-19 course, while others are a red flag for a more severe course. Knowledge of the cutaneous manifestations of COVID-19 may help in early diagnosis, triage of patients, and risk stratification.

Scurt CV

Prof. Lotti is Full Professor and Chairman of Dermatology and Venereology at University of Rome Guglielmo Marconi, Rome, Italy. He is President of the World Health Academy, Dermatology since 2013. Director, Centro Studi per la Ricerca Multidisciplinare Rigenerativa (CSRMR), of the University of Rome “G.Marconi”, Rome, Italy, since 2015.
He is Honorary Professor of Dermatology – China Medical University Shenyang (2011), Lecturer at the New York Academy of Sciences “Howard Fox Memorial Lecture” (14 March 2012 – New York, NY – USA), and Chair, Executive Scientific Committee Vitiligo Research Foundation, New York, NY USA. He has been Full Professor of the Dermatology and Venereology Division at University of Florence School of Medicine, Florence, Italy, from 2006 to 2010. He is Visiting Professor in six International Universities worldwide, and Key Note Lecturer in several international dermatology Societies.
His activities in serving Dermatology have been numerous: President of the Italian Society of Dermatology and Venereology (SIDeMaST , 2009-2011) and President of the International Society of Dermatology ( ISD, 2009-2011), President of the European Society for Cosmetic and Aesthetic Dermatology (2003-2004), Editor in Chief of the Journal of the European Academy of Dermatology and Venereology (1992-2002), Editor “Therapeutic Hotline”- Dermatologic Therapy (2007-) and served as Editor in Chief of the Giornale Italiano di Dermatologia in the period of presidency of the Societa’ Italiana di Dermatologia (2009-2011).
He is Ordinary Member of the main Scientific Societies worldwide (EADV, SIDEV, ESDR, ISD, AAD, SID) and Honorary Member of several Scientific Societies of the Dermatology field.
Moreover, he is a Scientific reviewer of ten sectorial journals, among which are the British Journal of Dermatology, Journal of Investigative Dermatology, Journal of the American Academy of Dermatology , Dermatologic Therapy.
Professor Lotti is presently Editor in Chief of Dermatologic Therapy by Wiley-Blackwell (Oxford U.K, Chicago IL).
Professor Lotti is Full Professor of Dermatology of the 1st Medical Univeristy of Moscow, since January 2020 and Full Professor and Chairman of Dermatology at Univeristy of Rome G. Marconi, Rome, Italy.
He has been invited as Keynote Speaker in 2.136 international and national Congresses and has served as Congress President or Chair of a Scientific session in 827 Congresses.
Prof. Lotti has authored 3.507 scientific publications (629 peer-reviewed articles, 388 book chapters, 3.650 abstracts and has edited or co-edited 59 books in the field of Dermatology and related fileds.

Prof. Dr. Davinder Parshad
Institute of Medical Education & Research, Chandigarh, India

Recent Advances in the Management of Vitiligo
Author: Davinder Parsad, MD, PhD
Professor, Department of Dermatology, PGIMER, Chandigarh, India

The development of effective treatment for vitiligo depends on understanding the mechanisms of depigmentation and repigmentation. In our continued journey to find ideal treatment of vitiligo, we have definitely reached a new era with effective medical treatment and non-cultured epidermal suspension in the management of vitiligo.
Vitiligo an auto-immune disease and there is need to emphasise on the early treatment of vitiligo. There are two treatment goals, one is stabilization and second is repigmentation. As vitiligo is associated with sever psycho-social stress, third goal can be to consider psychological aspects also in the management.
At present combination therapy is key to the successful management of vitiligo. In the present era of post phototherapy, we have a wide spectrum of many effective treatments for vitiligo; however, we do not have ideal treatment yet. In this presentation, I will be presenting an overview of roadmaps and roadblocks to the successful treatment of vitiligo based on the experience of last 20 years with emphasis on role of JAK/Stat inhibitors.

Scurt CV

Main area of research is vitiligo– pathogenesis and treatment and innovative surgical methods.
Total of 295 publications and about 140 publications on vitiligo only in International journals with very high citation index.
President –Asian Society for Pigment Cell Research (2011-2014).
Coordinator of Asian region for World Vitiligo consensus group.
Member: European Task force on vitiligo.
Member Scientific Advisory Board: Vitiligo Research Foundation (USA).
Council member of International Federation of Pigment Cell Societies.
Chaired/co-chaired, presented invited/guest lectures, papers on vitiligo at more than 200 International conferences/meetings.
Received Ambady oration of Indian Association of Dermatologists, Venereologists & Leprologists (2006).
Associate Editor: Archives of Dermatology Research and Dermatologic Therapy.
Member Editorial Board: International Journal of Dermatology.